Inhibition of interleukins 12 and 23- novel therapy for plaque psoriasis

Abstract

Therapeutic p40 blockade by anti-p40 monoclonal antibodies ustekinumab and briakinumab has proved to be an effective biological therapy in severe plaque psoriasis.

Keywords

• Biological therapy for psoriasis
• IL-12/23 blockers
• ustekinumab
• briakinumab